MedElevator Войти в исследования
← Поиск публикаций

DOI 10.5483/bmbrep.2022-0169

Медицинская библиотека · BMB reports · 2023

Alleviation of imiquimod-induced psoriasis-like symptoms in Rorα-deficient mouse skin.

Morelli Maria Beatrice, Amantini Consuelo, Santoni Matteo, Soriani Alessandra, Nabissi Massimo, Cardinali Claudio, Santoni Angela, Santoni Giorgio

НовостьПеревод пока не подготовлен

Аннотация

Tyrosine kinase inhibitors (TKIs) including axitinib have been introduced in the treatment of renal cell carcinoma (RCC) because of their anti-angiogenic properties. However, no evidence are presently available on a direct cytotoxic anti-tumor activity of axitinib in RCC.Herein we reported by western blot analysis that axitinib treatment induces a DNA damage response (DDR) initially characterized by γ-H2AX phosphorylation and Chk1 kinase activation and at later time points by p21 overexpression in A-498 and Caki-2 RCC cells although with a different potency. Analysis by immunocytochemistry for the presence of 8-oxo-7,8-dihydro-2'-deoxyguanosine in cellular DNA and flow cytometry using the redox-sensitive fluorescent dye DCFDA, demonstrated that DDR response is accompanied by the presence of oxidative DNA damage and reactive oxygen species (ROS) generation. This response leads to G2/M cell cycle arrest and induces a senescent-like phenotype accompanied by enlargement of cells and increased senescence-associated β-galactosidase activity, which are abrogated by N-acetyl cysteine (NAC) pre-treatment. In addition, axitinib-treated cells undergo to cell death through mitotic catastrophe characterized by micronucleation and abnormal microtubule assembly as assessed by fluorescence microscopy.On the other hand, axitinib, through the DDR induction, is also able to increase the surface NKG2D ligand expression. Accordingly, drug treatment promotes NK cell recognition and degranulation in A-498 RCC cells in a ROS-dependent manner.Collectively, our results indicate that both cytotoxic and immunomodulatory effects on RCC cells can contribute to axitinib anti-tumor activity.

Для цитирования: Morelli Maria Beatrice, Amantini Consuelo, Santoni Matteo, Soriani Alessandra, Nabissi Massimo, Cardinali Claudio, Santoni Angela, Santoni Giorgio. Alleviation of imiquimod-induced psoriasis-like symptoms in Rorα-deficient mouse skin.. BMB reports. 2023. DOI: 10.5483/bmbrep.2022-0169.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.